Clinical Trials Browser

Interventional × betrixaban × Classical hematology × Clear all

NCT01583218 2023-08-07

APEX

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism